GlassScriptPhysician profile
Stuart M Rosenblum
NPI 1144285982
$30,923.28
in general payments reported to CMS, 2019-2025
40 companies · $681 in 2025
The $681 reported for 2025 was more than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
See the full distribution for Pain Medicine (Anesthesiology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,752 · 2020: $1,122 · 2021: $21K · 2022: $1,242 · 2023: $1,566 · 2024: $3,457 · 2025: $681.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,690 · Consulting Fee: $1,944 · Travel and Lodging: $70.26.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,689.99 |
| Consulting Fee | $1,944.00 |
| Travel and Lodging | $70.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $20,448.21 | 2020-2025 | Qulipta, Ubrelvy, Botox |
| Tersera Therapeutics LLC | $2,431.54 | 2019-2025 | Prialt |
| Collegium Pharmaceutical, INC. | $1,248.39 | 2019-2025 | Belbuca, Xtampza, Nucynta |
| Allergan, INC. | $1,141.76 | 2019-2021 | |
| Medtronic, INC. | $763.41 | 2021-2025 | Intellis Adaptivestim, Synchromedii |
| Pfizer INC. | $651.59 | 2019-2025 | |
| Amgen INC. | $467.54 | 2019-2022 | |
| Lilly USA, LLC | $444.03 | 2019-2024 | Emgality, Reyvow, Amyvid |
| Lundbeck LLC | $284.31 | 2022-2024 | Vyepti |
| Teva Pharmaceuticals USA, INC. | $236.30 | 2019-2021 | |
| Medtronic USA, INC. | $224.95 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $216.17 | 2019-2021 | |
| Curonix LLC | $200.51 | 2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Flowonix Medical Incorporated | $196.78 | 2019 | |
| Scilex Pharmaceuticals INC. | $155.50 | 2019-2023 | Ztlido |
Show all 40 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stuart Rosenblum listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.